RESEARCH INTERESTS
My research focuses on the molecular mechanisms underlying vascular inflammation and cardiometabolic diseases, with a particular emphasis on atherosclerosis. I investigate how G protein-coupled receptors (GPCRs), immune signaling, mitochondrial function, and lipid metabolism regulate endothelial dysfunction, vascular inflammation, and disease progression. My research integrates transcriptomics, metabolomics, single-cell analysis, and experimental mouse models to identify novel therapeutic targets for cardiovascular disease. I am also interested in the transcriptomic mechanisms underlying biological sex differences in inflammatory and cardiovascular diseases, aiming to better understand sex-specific molecular regulation and its implications for disease pathogenesis and therapeutic development.
EDUCATION
- Harvard T.H. Chan School of Public Health, Master of Public Health (MPH),（2025-2027, expected)
- Postdoctoral Research Training, Lewis Katz School of Medicine at Temple University
- PhD, Biomedical Sciences, Lewis Katz School of Medicine at Temple University, Philadelphia, USA
- MS, Biotechnology, Northeastern University, Boston, USA
- MD, Harbin Medical University, China
MEMBERSHIPS
- American Heart Association (AHA)
- Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
AWARDS & HONORS
- American Heart Association Predoctoral Fellowship (2022-2023)
- American Heart Association Postdoctoral Fellowship (2024-2025)
- American Heart Association Career Development Award (2026-2029)
Publications:
My Bibliography: https://www.ncbi.nlm.nih.gov/myncbi/keman.xu.1/bibliography/public/